Global Healthcare Industry M&A and Capital Market Landscape 2024 Review

This report provides a comprehensive analysis of the global healthcare mergers and acquisitions (M&A) and capital market landscape for the year 2024. It highlights the healthy and broad-based deal activity within the healthcare sector, driven by accessible capital due to global interest rate cuts. The report outlines key sentiments observed in M&A, including moderate valuations and portfolio realignment among strategics. It also discusses the rebound in healthcare funding volumes and the resurgence of initial public offerings as a primary exit method for investors. The report emphasizes the importance of innovative deal structures in the context of SPACs and the growing relevance of environmental, social, and governance (ESG) factors in M&A strategies. Looking ahead to 2025, the report anticipates increased deal activity, particularly in the pharmaceutical and biotech sectors, driven by favorable market conditions and the need for companies to transform their business models. The document serves as a valuable resource for stakeholders in the healthcare industry seeking to understand the evolving M&A landscape.